💊#FDA Approval Update | Belantamab mafodotin-#blmf (#Blenrap)
👉Approved in combination with #bortezomib and #dexamethasone
👉For adult patients with relapsed or refractory #MM, received at least one line of prior therapy
🌟We provide #BelantamabMafodotin, #Belantamab, and #McMMAF for research use.

FDA Approval of Belantamab - Dana-Farber Cancer Institute's Role in the Drug Development - OncoDaily FDA Approval of Belantamab - Dana-Farber Cancer Institute's Role in the Drug Development / belantamab, belantamab mafodotin, blmf, cancer, Dana-Farber Cancer

FDA Approval of Belantamab - Dana-Farber Cancer Institute’s Role in the Drug Development

@fda.gov @danafarber.bsky.social @danafarbernews.bsky.social

oncodaily.com/community/be...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MM #RRMM #Myeloma #DanaFarber #Belantamab

#gsk #glaxoSmithkline #blenrep #belantamab #mafodotin #blood-cancer #multiple-myeloma #hematologic-cancer #us-fda #fda-panel #drug-approval #drug-safety #advisory-panel #oncology #cancer-treatment #adverse-event-review